Gumboriffa vakcina A.U.V.
Gumboriffa vakcina A.U.V.
Authorised
- Infectious bursal disease virus, strain VNJO, Inactivated
Product identification
Medicine name:
Gumboriffa vakcina A.U.V.
Active substance:
- Infectious bursal disease virus, strain VNJO, Inactivated
Target species:
-
Chicken
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain VNJO, Inactivated4.40/log10 virus neutralising unit(s)1.00unit(s)/dose
Pharmaceutical form:
-
Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
